glp 1 postmenopausal GLP-1s, Obesity, and Menopause: Benefits and Risks Can hormone therapy support better

A large retrospective cohort study of 111,646 overweight or obese women found that GLP-1 agonist exposure was associated with lower breast cancer incidence

Their pleiotropic benefits arise from intricate signalling cascades that regulate appetite, insulin secretion, and energy homeostasis across multiple tissues.

He runs his clients on a version of Tim Ferrisss 30-30-30 method Read MoreGary Breckas Diet (2026) His Personal Routine & Diet Guidelines

This brief examines the financialized business model of Novo Nordisk and Eli Lilly for the leading GLP-1 products Ozempic, Rybelsus, and Wegovy (semaglutide) and Mounjaro and Zepbound (tirzepatide)

Heres what you can do about it.

GLP-1s can negatively affect overall bone health, contributing to conditions like